Pacific Biosciences of California, Inc.
PACB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $56 | $55 | $59 | $55 |
| Short-Term Investments | $242 | $260 | $285 | $335 |
| Receivables | $31 | $32 | $32 | $28 |
| Inventory | $53 | $54 | $54 | $59 |
| Other Curr. Assets | $12 | $13 | $16 | $19 |
| Total Curr. Assets | $394 | $413 | $445 | $496 |
| Property Plant & Equip (Net) | $65 | $67 | $69 | $47 |
| Goodwill | $318 | $318 | $318 | $318 |
| Intangibles | $16 | $17 | $18 | $390 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $10 | $11 | $11 | $11 |
| Total NC Assets | $409 | $412 | $416 | $765 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $803 | $825 | $861 | $1,260 |
| Liabilities | – | – | – | – |
| Payables | $16 | $15 | $14 | $17 |
| Short-Term Debt | $4 | $1 | $2 | $10 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $15 | $15 | $14 |
| Other Curr. Liab. | $43 | $29 | $35 | $26 |
| Total Curr. Liab. | $63 | $60 | $67 | $66 |
| LT Debt | $699 | $699 | $697 | $662 |
| Deferred Rev, NC | $0 | $6 | $6 | $6 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $0 | $0 | $19 |
| Total NC Liab. | $704 | $704 | $703 | $688 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $55 | $53 | $53 | $25 |
| Total Liabilities | $767 | $764 | $769 | $754 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,655 | -$2,617 | -$2,575 | -$2,149 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $2,690 | $2,678 | $2,666 | $2,655 |
| Total Equity | $36 | $61 | $92 | $507 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $803 | $825 | $861 | $1,260 |
| Net Debt | $647 | $644 | $641 | $617 |